iASPP can promote autoimmune responses in vivo by limiting Treg cell activation, while also enhancing cancer immunosurveillance by inhibiting T cell exhaustion and antagonizing Treg and γδ T cell-mediated immune tolerance. This evidence concerns the gene PPP1R13L and cancer.